Improvement of cardiac function after implanting the osteopontin-derived peptide SVVYGLR in a hamster model of dilated cardiomyopathy.

@article{Mizuno2015ImprovementOC,
  title={Improvement of cardiac function after implanting the osteopontin-derived peptide SVVYGLR in a hamster model of dilated cardiomyopathy.},
  author={Y. Mizuno and A. Uchinaka and Y. Horii and S. Mori and Y. Hamada and S. Miyagawa and A. Saito and Y. Sawa and N. Matsuura and N. Kawaguchi},
  journal={Interactive cardiovascular and thoracic surgery},
  year={2015},
  volume={21 4},
  pages={
          506-14
        }
}
OBJECTIVES Osteopontin is a multifunctional cytokine that can modulate a variety of cellular activities, such as fibrotic response and inflammation. Osteopontin-derived peptide Ser-Val-Val-Tyr-Gly-Leu-Arg (SVVYGLR; SV) induces angiogenesis and the expression of smooth muscle actin (SMA) in fibroblasts. In this study, we determined the effects of SV peptide on dilated cardiomyopathy (DCM). METHODS Gels containing SV peptide (SV group), a random SV peptide (GYRVLSV) (random group) or a simple… Expand
Evaluation of dermal wound healing activity of synthetic peptide SVVYGLR.
Overexpression of collagen type III in injured myocardium prevents cardiac systolic dysfunction by changing the balance of collagen distribution

References

SHOWING 1-10 OF 25 REFERENCES
Transplantation of myoblast sheets that secrete the novel peptide SVVYGLR improves cardiac function in failing hearts.
Osteopontin-derived peptide SVVYGLR induces angiogenesis in vivo.
Enhanced bone regeneration via multimodal actions of synthetic peptide SVVYGLR on osteoprogenitors and osteoclasts.
Synthetic osteopontin-derived peptide SVVYGLR can induce neovascularization in artificial bone marrow scaffold biomaterials.
Angiogenic activity of osteopontin-derived peptide SVVYGLR.
Enhanced deposition of predominantly type I collagen in myocardial disease.
Cardiac interstitium in health and disease: the fibrillar collagen network.
  • K. Weber
  • Medicine
  • Journal of the American College of Cardiology
  • 1989
Smad3 Signaling Critically Regulates Fibroblast Phenotype and Function in Healing Myocardial Infarction
Cardiac contractile dysfunction in J2N-k cardiomyopathic hamsters is associated with impaired SR function and regulation.
Tissue inhibitor of metalloproteinase-1 and -3 improves cardiac function in an ischemic cardiomyopathy model rat.
...
1
2
3
...